Mark J. Ratain to Immunotherapy
This is a "connection" page, showing publications Mark J. Ratain has written about Immunotherapy.
Connection Strength
0.566
-
Immunotherapy and the A2A Adenosine Receptor: A Confounding Brew. Clin Pharmacol Ther. 2019 09; 106(3):498-500.
Score: 0.446
-
Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors. Br J Clin Pharmacol. 2020 09; 86(9):1769-1777.
Score: 0.121